VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $118 | -31.4% | 55,555 | 0.0% | 0.00% | -33.3% |
Q2 2023 | $172 | -42.5% | 55,555 | 0.0% | 0.01% | -45.5% |
Q1 2023 | $299 | -19.0% | 55,555 | 0.0% | 0.01% | -21.4% |
Q4 2022 | $369 | -99.8% | 55,555 | 0.0% | 0.01% | +55.6% |
Q3 2022 | $221,000 | -19.9% | 55,555 | 0.0% | 0.01% | -18.2% |
Q2 2022 | $276,000 | -17.9% | 55,555 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $336,000 | -48.0% | 55,555 | 0.0% | 0.01% | -47.6% |
Q4 2021 | $646,000 | -25.8% | 55,555 | 0.0% | 0.02% | -27.6% |
Q3 2021 | $871,000 | -15.9% | 55,555 | 0.0% | 0.03% | -12.1% |
Q2 2021 | $1,036,000 | -56.7% | 55,555 | 0.0% | 0.03% | -60.7% |
Q1 2021 | $2,394,000 | – | 55,555 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,361,723 | $13,486,853 | 3.88% |
OUP Management Co., LLC | 374,714 | $794,394 | 1.79% |
RA Capital Management | 22,748,880 | $48,227,626 | 0.95% |
Paradigm Biocapital Advisors LP | 6,461,467 | $13,698,310 | 0.93% |
JOHNSON & JOHNSON | 1,074,658 | $2,278,275 | 0.84% |
Trustees of Columbia University in the City of New York | 91,910 | $194,849 | 0.36% |
Artal Group S.A. | 2,688,015 | $5,699 | 0.24% |
Sarissa Capital Management LP | 618,000 | $1,310,160 | 0.18% |
Laurion Capital Management LP | 3,182,889 | $6,747,724 | 0.04% |
Woodline Partners LP | 1,111,123 | $2,355,581 | 0.03% |